The classic website will no longer be available as of June 25, 2024. Please use the modernized

Key Record Dates Identifier: NCT05429268
Brief Title: Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND) (firmMIND)

First Submitted : June 17, 2022
First Submitted that Met QC Criteria : June 17, 2022
First Posted : June 23, 2022

Last Update Submitted that Met QC Criteria : May 2, 2024
Last Update Posted : May 3, 2024